Wales has become the first country in the world to launch specialized Intensive Learning Academies (ILAs) that will deliver transformational training and support across preventative health, value-based health and care, and innovations in health and social care.
Welsh universities have created a range of flexible courses that include degree-level opportunities within these growing fields. They are open for professionals from the health and social care, and life sciences sectors across the globe to learn together.
Led by Swansea University and Bangor University, the ILAs are also delivering research and tailor-made consultancy services. This will support individual organizations to identify, develop and collaborate on innovative practices that will help to meet the challenges facing health and social care.
The three ILAs will commence activities across 2021, with each specializing in a subject identified as a key future growth area for the global health and social care markets:
All courses will welcome applicants working across global health, social care, and life sciences systems. There are ILA scholarships available for those working within the health, social care and third sector within Wales and internationally, and for those who wish to retrain to join the sector.
Applications are now open for the bespoke programs, with more information available on the Life Sciences Hub Wales website.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.